CNST - コンステレ―ション・ファ―マシュ―ティカルズ (Constellation Pharmaceuticals Inc.)

CNSTのニュース

   MorphoSys at a historic low as it completes acquisition of Constellation Pharma  2021/07/15 13:28:58 Seeking Alpha
   MorphoSys AG: MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology  2021/07/15 06:32:00 FinanzNachrichten
Company Announces Successful Completion of Tender Offer Moves Forward with Strategic Funding Partnership with Royalty PharmaPLANEGG / MUNICH, GERMANY / ACCESSWIRE / July 15, 2021 / MorphoSys AG (FS
   MorphoSys AG: MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals  2021/07/01 14:56:00 FinanzNachrichten
MUNICH, GERMANY and WILMINGTON, DE / ACCESSWIRE / July 1, 2021 / MorphoSys AG (FSE:MOR) (NASDAQ:MOR) ("MorphoSys") today announced the expiration of the waiting period under the Hart-Scott-Rodino A
   MorphoSys Gets U.S. Antitrust Approval For Constellation Pharma Deal  2021/07/01 14:36:05 Business Insider Markets
(RTTNews) - MorphoSys AG (MOR) announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, for its tender offer for Constellation Pharmaceuticals Inc. (CNST). The expiration of the HSR waiting period satisfies one of the conditions to the tender offer, which is scheduled to expire
   DGAP-News: MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals  2021/07/01 14:19:04 Wallstreet:Online
DGAP-News: MorphoSys AG / Key word(s): Mergers & Acquisitions MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals 01.07.2021 / 16:19 The issuer is solely responsible for the content of this announcement. Media Release MorphoSys Announces
   MorphoSys AG: MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals  2021/07/01 14:56:00 FinanzNachrichten
MUNICH, GERMANY and WILMINGTON, DE / ACCESSWIRE / July 1, 2021 / MorphoSys AG (FSE:MOR) (NASDAQ:MOR) ("MorphoSys") today announced the expiration of the waiting period under the Hart-Scott-Rodino A
   MorphoSys Gets U.S. Antitrust Approval For Constellation Pharma Deal  2021/07/01 14:36:05 Business Insider Markets
(RTTNews) - MorphoSys AG (MOR) announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, for its tender offer for Constellation Pharmaceuticals Inc. (CNST). The expiration of the HSR waiting period satisfies one of the conditions to the tender offer, which is scheduled to expire
   DGAP-News: MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals  2021/07/01 14:19:04 Wallstreet:Online
DGAP-News: MorphoSys AG / Key word(s): Mergers & Acquisitions MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals 01.07.2021 / 16:19 The issuer is solely responsible for the content of this announcement. Media Release MorphoSys Announces
   Constellation Pharmaceuticals says HSR waiting period expired for its planned sale to MorphoSys  2021/07/01 12:45:13 Seeking Alpha
   Lifshitz Law Firm, P.C. Announces Investigation of CNST, FFWM, SLCT, and GRA  2021/06/30 14:39:00 Intrado Digital Media
NEW YORK, June 30, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (NasdaqGS: CNST)
   MorphoSys AG: MorphoSys Commences Cash Tender Offer for All Outstanding Shares of Constellation Pharmaceuticals  2021/06/16 22:20:00 FinanzNachrichten
PLANEGG, GERMANY / ACCESSWIRE / June 16, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) ("MorphoSys") today announced that it is commencing a cash tender offer to purchase all outstanding shares of Cons
   MorphoSys Commences Cash Tender Offer for All Outstanding Shares of Constellation Pharmaceuticals  2021/06/16 22:15:00 Wallstreet:Online
PLANEGG, GERMANY / ACCESSWIRE / June 16, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) ("MorphoSys") today announced that it is commencing a cash tender offer to purchase all outstanding shares of Constellation Pharmaceuticals, Inc., (CNST)
   DGAP-News: MorphoSys Commences Cash Tender Offer for All Outstanding Shares of Constellation Pharmaceuticals  2021/06/16 21:43:05 Wallstreet:Online
DGAP-News: MorphoSys AG / Key word(s): Mergers & Acquisitions MorphoSys Commences Cash Tender Offer for All Outstanding Shares of Constellation Pharmaceuticals 16.06.2021 / 23:43 The issuer is solely responsible for the content of this announcement. Media Release MorphoSys Commences Cash Tender
   Lifshitz Law Firm, P.C. Announces Investigation of CNST, EQT, FFWM, TGRF, MDP, MMAC, QTS, SLCT, FBNC, USCR  2021/06/12 00:15:00 PR Newswire Media
NEW YORK, June 11, 2021 /PRNewswire/ -- Constellation Pharmaceuticals, Inc. (NasdaqGS: CNST) MorphoSys AG (NasdaqGS: MOR) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of CNST to MOR for $34.00 in cash per share. If
   Constellation Pharma presents mid-stage data for pelabresib in myelofibrosis  2021/06/11 14:30:23 Seeking Alpha

calendar